Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kerry Anne McEachern
Observed names:
K.A. McEachern,
Kerry McEachern,
KerryAnne McEachern
OpenAlex ID:
A5113645003
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease
2007
·
Kerry Anne McEachern
, John Fung
, et al.
·
Molecular Genetics and Metabolism
·
185
Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease
2010
·
John Marshall
, Karen M. Ashe
, et al.
·
PLoS ONE
·
79
PDF
AAV8‐mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease
2006
·
Kerry Anne McEachern
, Jennifer B. Nietupski
, et al.
·
The Journal of Gene Medicine
·
70
Demonstration of Feasibility of In Vivo Gene Therapy for Gaucher Disease Using a Chemically Induced Mouse Model
2002
·
John Marshall
, Kerry Anne McEachern
, et al.
·
Molecular Therapy
·
59
PDF
Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy
2010
·
John Marshall
, Kerry Anne McEachern
, et al.
·
Journal of Inherited Metabolic Disease
·
48
24 Genz-112638: A novel orally available ceramide-based inhibitor of glucosylceramide synthase for treating Gaucher disease
2007
·
Kerry McEachern
, C. Siegel
, et al.
·
Molecular Genetics and Metabolism
·
1
Show more works
View as search
Works count:
7
Citation count:
442
H-index:
5
I10-index:
5
Year
Topic
Type